ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print April 26, 2006, 10.1183/09031936.06.00063505
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muller, W. G.
Right arrow Articles by Jaffe, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muller, W. G.
Right arrow Articles by Jaffe, A.
Eur Respir J 2006; 28:479-485
Copyright ©ERS Journals Ltd 2006

Safety and feasibility of exhaled breath condensate collection in ventilated infants and children

W. G. Muller1, F. Morini2, S. Eaton2, M. Peters1 and A. Jaffe1

1 Portex Anaesthesia, Intensive Therapy and Respiratory Medicine Unit, and 2 Dept of Paediatric Surgery, Institute of Child Health and Great Ormond Street Hospital for Children National Health Service Trust, London, UK.

CORRESPONDENCE: A. Jaffe, Portex Respiratory Medicine Group, Level 6, Cardiac Wing, Great Ormond Street Hospital for Children and Institute of Child Health, Great Ormond Street, London WC1N 3JH, UK. Fax: 44 2078298634. E-mail: ajaffe{at}doctors.org.uk

Keywords: Exhaled breath condensate, 8-isoprostane, safety, ventilation

Received: May 31, 2005
Accepted April 12, 2006

The aim of this study was to develop a technique for the collection of exhaled breath condensate (EBC) from ventilated children and assess its safety and feasibility. Collection of EBC is used to investigate markers of oxidative stress in the lower airway. No studies have assessed its safety in ventilated children.

An in vitro model was developed by connecting a ventilator to an artificial lung; 14 clinical and ventilatory parameters were measured during EBC collection from ventilated children. Levels of 8-isoprostane were measured following collection with and without humidification of the inhaled gas.

Amount of water vapour collected was linearly related to time and to minute ventilation in the in vitro model. EBC collections (n = 68) were made from ventilated children. In the nonhumidified group, the mean (range) positive end-expiratory pressure increased by 4.1% (2.8–5.5%) and the peak inspiratory flow decreased by 6.1% (11.0–1.3%) during collection. Detectable levels of 8-isoprostane were only found in 10 out of 18 nonhumidified EBC samples (median (range) 4.7 pg·mL-1 (0–5.8)).

Collection of exhaled breath condensate from ventilated infants and children is feasible and safe. Discontinuation of humidification is likely to be important in standardising the measurement of inflammatory parameters in exhaled breath condensate collected from ventilated children.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.